Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Prostate Cancer, mHSPC

Matthew Rettig

MD

🏢UCLA Jonsson Comprehensive Cancer Center / VA Greater Los Angeles🌐USA

Chief, Hematology-Oncology; Professor of Medicine and Urology

47
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Matthew Rettig is a prostate cancer specialist at UCLA who has contributed to clinical trials and translational investigations in metastatic hormone-sensitive prostate cancer, including studies on abiraterone combinations and understanding resistance mechanisms. His work bridges basic science discoveries in AR biology with clinical trial design for mHSPC. He has led VA-based cancer research programs that address health disparities and access to novel therapies in mHSPC. Rettig's research also examines genomic determinants of response to ADT intensification.

Share:

🧪Research Fields 研究领域

mHSPC clinical trials
abiraterone mHSPC data
triplet therapy feasibility
PSA kinetics mHSPC
hormonal therapy sequencing mHSPC

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Matthew Rettig 的研究动态

Follow Matthew Rettig's research updates

留下邮箱,当我们发布与 Matthew Rettig(UCLA Jonsson Comprehensive Cancer Center / VA Greater Los Angeles)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment